Trump and Schumer's Support of Marijuana Could be a Major Catalyst for These Companies

LAS VEGAS, April 23, 2018 /PRNewswire/ --

FN Media Group Presents Microcapspeculators.com News Commentary 

On April 13th President Donald Trump announced unprecedented support of legalizing marijuana. This is a very big step for companies that are researching CBDs and other cannabidiol products for consumers, and patients. Jeff Sessions, the current Attorney General, has been extremely anti-marijuana, but Trump is in support of states' rights to decide their own marijuana laws. 

Just days later, Chuck Schumer and the democrats introduced legislation to decriminalize marijuana on the federal level. This is extremely important as it pertains to the ability of firms to research marijuana and, more importantly, cannabinoids. These moves by democrats, and the President, could be a massive catalyst for companies involved in the CBDs. 

Some companies that are researching CBD and other cannabinoids include: NightFood Holdings, Inc. (OTC: NGTF), GW Pharmaceuticals plc (NASDAQ: GWPH), INSYS Therapeutics, Inc. (NASDAQ: INSY), Terra Tech Corp. (OTC: TRTC), and General Cannabis Corp. (OTC: CANN).

NightFood Holdings, Inc. (OTC: NGTF)

Market Cap: $16.04M, current share price: $.419 

NGTF the category leading, better-for-you, sleep-friendly nighttime snack company, had two major news releases in the last week. In January of 2018, MJ Munchies, Inc. a wholly owned subsidiary of NGTF, filed with the United States Patent and Trademark Office for trademark protection related to the Half-Baked™ brand. Shortly thereafter the company acquired HalfBaked.com.  

On April 16th NGTF announced that it has identified its first licensing partner in the state of California for THC- infused edibles through its Half-Baked trademark. On April 20th NGTF announced that the licensing agreement had been finalized and executed, and the initial production run of Half-Baked cannabis-infused cookies should be on shelves in May of 2018. The company views this initial licensing agreement and production run as the first step to licensing the Half-Baked™ brand to licensees in states across the country, turning Half-Baked into a national edibles brand.   The company's CEO stated "We think Half-Baked™ is simply the best brand name in the space."  

GW Pharmaceuticals plc (NASDAQ: GWPH)

Market Cap: $3.735B, current share price: $136.62 

GWPH, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, received the nod for an FDA panel for the company's cannabidiol product. Paving the way for the drug Epidiolex to be the first cannabis-based drug nearing FDA approval. The FDA panel voted 13-0 in favor of GW's drug, and Cowen analysts have said to expect $1.3 bln in sales by 2022.  

INSYS Therapeutics, Inc. (NASDAQ: INSY)

Market Cap: $518.6M, current share price: $6.96 

INSY a leader in the development, manufacture, and commercialization of pharmaceutical cannabinoids recently announced that the company would advance clinical research of Dronabinol Inhalation using novel breath-actuated device. The company's security is down more than 50% from it's 52 week-high.

Terra Tech Corp. (OTCQX: TRTC)

Market Cap: $205.8M, current share price: $3.15 

TRTC, a vertically integrated cannabis-focused agriculture company,  reported record revenues for the period ending December 31st, 2017. The company's security is down approximately 66% from its 52 week-high.  

General Cannabis Corp. (OTCQB: CANN)

Market Cap: $148.1M, current share price: $4.18 

CANN, recently announced that the company had closed a private financing. The company issued $5.54 million of senior secured promissory notes and an aggregate of 4,432,000 warrants to purchase common stock at the closing. The proceeds of this debt raise will be used primarily to fund the Company's expansion and for working capital. The company's CEO stated "This new capital raise will allow us to continue to deliver increased value to our shareholders."

Content Provided By: Microcap Speculators

Email: [email protected]

Phone: 1-702-720-6310

Website: http://microcapspeculators.com/

For Full Legal Disclaimer Click Here.

DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.

MS Disclosure:  Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and MS and FNM undertake no obligation to update such statements.

Media Contact
FN Media Group LLC
e-mail: [email protected]  
(954)-345-0611

SOURCE Microcapspeculators.com